Drug & Medicine News
Timely news from pharmaceutical companies and health regulators — reviewed and rewritten by our editorial team.
SPONSORED CONTENT
Sponsored headline goes here
One or two sentences describing the sponsor’s message, written by the advertiser and clearly separated from independent editorial content.
-
Johnson & Johnson Advances Cardiac Ablation Technology in Europe with Availability of Dual Energy THERMOCOOL SMARTTOUCH SF Platform
The Dual Energy THERMOCOOL SMARTTOUCH SF Platform combines pulsed field and radiofrequency energy delivery in a unified and integrated treatment platformi
-
Johnson & Johnson Begins Enrollment in Pivotal Studies Evaluating First-of-its-Kind Carotid IVL Platform
· U.S. IDE study program will evaluate the purpose-built Shockwave™ SkyRunner Carotid IVL System designed to address the challenges of calcification in…
-
CHMP recommendation advances Johnson & Johnson’s TECVAYLI®▼ (teclistamab) plus daratumumab as a potential standard of care for relapsed/refractory multiple myeloma
Recommendation supported by unprecedented Phase 3 data, demonstrating that TECVAYLI® in combination with daratumumab achieved statistically significant improvements in progression-free and overall…
-
Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!